Jedd Wolchok
MD, PhD
Director, Parker Institute for Cancer Immunotherapy at MSK
👥Biography 个人简介
Jedd Wolchok led the landmark CheckMate-067 trial demonstrating superior overall survival with nivolumab plus ipilimumab versus either agent alone in advanced melanoma. His translational research has elucidated mechanisms of checkpoint inhibitor activity and the basis for long-term durable responses in melanoma. He has been a central figure in the evolution of combination immunotherapy from concept to clinical practice.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Jedd Wolchok 的研究动态
Follow Jedd Wolchok's research updates
留下邮箱，当我们发布与 Jedd Wolchok（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment